| Name | Title | Contact Details |
|---|
Oakcrest Manors is a Jenison, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PLT Health Solutions is a discoverer, developer, and marketer of high-quality, scientifically-supported ingredient solutions for the natural products, food & beverage and cosmeceuticals markets. Our goal is to bring innovative and impactful solutions that help our consumer products customers develop new concepts, new products and grow successful brands. An important part of our ability to serve our customers is our network of global strategic partnerships. Our partners are some of the world`s most innovative people, and we help bring them and their companies to market via proprietary ingredient brands with the type of support services that are required by leading consumer products companies. This dual role of solution provider to health & wellness consumer companies and commercialization partner for international ingredient suppliers is one of the things that make us unique in the industry.
Lead Health is a national healthcare staffing firm based in California that provides opportunities in travel nursing, per diem nursing, and allied healthcare.
Heska is dedicated to quality pet care. Through innovation, invention, and strategic partnerships with worldwide leaders in diagnostics and treatments, Heska provides the benefits of latest generation technologies to pet healthcare providers. Heska`s range of complete blood diagnostic solutions include Chemistry, Hematology, Blood Gas & Electrolytes, Immunodiagnostics, Heartworm, and other blood testing. Treatments and testing include Immunotherapy and complete Allergy solutions. Heska`s digital imaging lineup boasts the latest High Definition Digital Radiography and Digital Ultrasound technologies, paired with Cloud Based data archival, management, and sharing services.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.